Prescribing radiation dose to lung cancer patients based on personalized toxicity estimates.
Publication/Presentation Date
11-1-2012
Abstract
INTRODUCTION: The lung radiosensitivity of the most sensitive patients limits doses that can be given to the majority of lung cancer patients. The purpose of the current study was to illustrate the concept of personalizing prescription dose by performing a retrospective study in which the prescription is determined using an individualized dose-volume constraint that is calculated from a toxicity prediction model. We test whether using a model-generated personalized lung-dose limit results in a clinically significant change to the prescription.
METHODS: A model consisting of a dose-volume component and a genetic component (single-nucleotide polymorphism information) was used to determine iso-risk mean lung-dose (MLD) limits for each patient. The prescription dose for each patient was scaled according to the individualized MLD constraint and population-based constraints for the cord, esophagus, and heart. The difference between the model-determined prescription dose and the prescription the patient was originally treated with was evaluated.
RESULTS: For 59% of the patients the change in prescription using the model-determined limit was greater than 5 Gy (either dose escalation or de-escalation). For 96% of the patients who developed radiation pneumonitis the model predicted that the prescription should have been lowered.
CONCLUSIONS: Our results indicate that using a model-generated personalized MLD results in a clinically different (≥ 5 Gy) prescription. A model used in the manner described by the study can help physicians further personalize radiation therapy and aid them in determining how much dose can safely be delivered to the tumor and normal tissues.
Volume
7
Issue
11
First Page
1676
Last Page
1682
ISSN
1556-1380
Published In/Presented At
Vinogradskiy, Y., Tucker, S. L., Bluett, J. B., Wages, C. A., Liao, Z., & Martel, M. K. (2012). Prescribing radiation dose to lung cancer patients based on personalized toxicity estimates. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 7(11), 1676–1682. https://doi.org/10.1097/JTO.0b013e318269410a
Disciplines
Medicine and Health Sciences | Pediatrics
PubMedID
23059778
Department(s)
Administration and Leadership
Document Type
Article